✦ LIBER ✦

Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells

✍ Scribed by Zakikhani, M.; Dowling, R.; Fantus, I. G.; Sonenberg, N.; Pollak, M.

Book ID: 126962081
Publisher: American Association for Cancer Research
Year: 2006
Tongue: English
Weight: 329 KB
Volume: 66
Category: Article
ISSN: 0008-5472
DOI: 10.1158/0008-5472.can-06-1500

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

423 POSTER Metformin is an AMP-kinase de

423 POSTER Metformin is an AMP-kinase dependent growth inhibitor for breast cancer cells

✍ M. Zakikhani; R. Dowling; I.G. Fantus; N. Sonenberg; M.-J. Blouin; M. Pollak 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Metformin attenuates ovarian cancer cell

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner

✍ R. Rattan; S. Giri; L.C. Hartmann; V. Shridhar 📂 Article 📅 2009 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 925 KB

Honokiol activates AMP-activated protein

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

✍ Arumugam Nagalingam, Jack L Arbiser, Michael Y Bonner, Neeraj K Saxena, Dipali S 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 987 KB

The EGFR-selective tyrosine kinase inhib

The EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’) is an effective inhibitor of tamoxifen-resistant breast cancer growth

✍ J. Gee; I. Hutcheson; J. Knowlden; D. Barrow; M. Harper; H. Jones; A. Wakeling; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Tyrosine kinase inhibitors as antiprolif

Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro

✍ Twaddle, George M.; Turbov, Jane; Liu, Naxin; Murthy, Satya 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Background and Objectives: Receptor tyrosine kinase (RTK) activation is critical for growth factor-mediated cell proliferation. Blockade of RTK activation inhibits growth factor-induced cell proliferation. A panel of RTK inhibitors (tyrphostins) have been tested and compared for their antiproliferat

PD-0332991, a cyclin-dependent kinase 4/

PD-0332991, a cyclin-dependent kinase 4/6 inhibitor, is an active agent in uterine cancer cells

✍ Ducie, J.A.; Jelinic, P.; Zhang, Z.; Dao, F.; Bisogna, M.; Makker, V.; Levine, D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB